Correlation Between Apogee Therapeutics, and ChampionX
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and ChampionX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and ChampionX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and ChampionX, you can compare the effects of market volatilities on Apogee Therapeutics, and ChampionX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of ChampionX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and ChampionX.
Diversification Opportunities for Apogee Therapeutics, and ChampionX
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Apogee and ChampionX is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and ChampionX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChampionX and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with ChampionX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChampionX has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and ChampionX go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and ChampionX
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the ChampionX. In addition to that, Apogee Therapeutics, is 2.03 times more volatile than ChampionX. It trades about -0.14 of its total potential returns per unit of risk. ChampionX is currently generating about 0.08 per unit of volatility. If you would invest 2,757 in ChampionX on November 9, 2024 and sell it today you would earn a total of 98.00 from holding ChampionX or generate 3.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. ChampionX
Performance |
| Timeline |
| Apogee Therapeutics, |
| ChampionX |
Apogee Therapeutics, and ChampionX Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and ChampionX
The main advantage of trading using opposite Apogee Therapeutics, and ChampionX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, ChampionX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChampionX will offset losses from the drop in ChampionX's long position.| Apogee Therapeutics, vs. Xunlei Ltd Adr | Apogee Therapeutics, vs. Grocery Outlet Holding | Apogee Therapeutics, vs. WPP PLC ADR | Apogee Therapeutics, vs. Cimpress NV |
| ChampionX vs. Expro Group Holdings | ChampionX vs. Ranger Energy Services | ChampionX vs. Cactus Inc | ChampionX vs. MRC Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |